Correction to Lancet Neurol 2019; 18: 145-54
- PMID: 30665722
- DOI: 10.1016/S1474-4422(19)30014-6
Correction to Lancet Neurol 2019; 18: 145-54
Erratum for
-
Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial.Lancet Neurol. 2019 Feb;18(2):145-154. doi: 10.1016/S1474-4422(18)30405-8. Lancet Neurol. 2019. PMID: 30663606 Clinical Trial.
Similar articles
-
Correction to Lancet Neurol 2020; 19: 247-54.Lancet Neurol. 2020 Mar;19(3):e3. doi: 10.1016/S1474-4422(20)30040-5. Lancet Neurol. 2020. PMID: 32085837 No abstract available.
-
Correction to Lancet Neurol 2019; 18: 1078-79.Lancet Neurol. 2020 Feb;19(2):e2. doi: 10.1016/S1474-4422(19)30482-X. Lancet Neurol. 2020. PMID: 31978360 No abstract available.
-
Correction to Lancet Neurol 2018; 17: 597-608.Lancet Neurol. 2020 Feb;19(2):e2. doi: 10.1016/S1474-4422(19)30479-X. Lancet Neurol. 2020. PMID: 31978359 No abstract available.
-
Correction to Lancet Neurol 2019; 18: 329-31.Lancet Neurol. 2019 Sep;18(9):e8. doi: 10.1016/S1474-4422(19)30251-0. Epub 2019 Jul 8. Lancet Neurol. 2019. PMID: 31296370 No abstract available.
-
Cerebrovascular neurosurgery 2014.J Clin Neurosci. 2015 May;22(5):775-8. doi: 10.1016/j.jocn.2015.01.002. Epub 2015 Feb 15. J Clin Neurosci. 2015. PMID: 25691077 Review.
Publication types
LinkOut - more resources
Full Text Sources